Navigation Links
Exhaustive Study to Expand the Efficacy of Drug L-dopa for Parkinson's

Parkinson's sufferers are usually treated with the drug called levodopa or L-dopa that helps in reviving cellular communication//. After prolonged use of the drug, many patients may experience motor complications and a reduced response to the drug.

Parkinson's disease is a slow process of destruction of brain cells which produce dopamine. As dopamine levels fall, the symptoms of Parkinson’s shows up as tremors in the arms, legs and face. The patients visibly portray slow movement, lack of proper balance and coordination.

A new clinical trial is underway to evaluate the effectiveness of a novel drug to treat Parkinson’s, which could extend the benefits of he existing drug, L-dopa. The study will also investigate the potential of the drug, E2007, and its contribution in extending the effectiveness of L-dopa.

The prevailing treatment for Parkinson's disease aims to revive cellular communication by simply restoring the lost dopamine with L-dopa. Though this therapy is effective for sometime, yet it is unable to halt the gradual decline so evident in long time Parkinson’s sufferers.

"The hope is that by altering dopamine transmission through the modulating the activity of AMPA receptors, there will be measurable effects on the dopamine system," said Dr. Liang.

The study has been tailored to suit patients suffering advanced Parkinson's and have been undergoing L-dopa treatment for a considerable period of time. The study will involve nearly 700 patients from more than 100 centers across the U.S., Canada, Australia, New Zealand and South America.

Dr. Kremens said, "It's an interesting approach and an exciting trial because it is exploring a drug in a new therapeutic category. L-dopa is still the gold standard and we haven't come up with a better dopamine as yet."
'"/>




Page: 1

Related medicine news :

1. Dolly Paves the Way for Exhaustive Stem Cell Research
2. Cancer Drug Helps An Anti-Cancer Virus To Act More Exhaustively
3. Tomato Sauce reduces Cancer Risk- Study
4. Study on obesity and heart failure
5. National Lung Study in the process
6. Study casts doubt on keyboard ills
7. Study reveals how stress can make you sick
8. Study reveals how stress can make you sick
9. Study supports vegetable diet
10. Study to look at early surgery to treat epilepsy
11. Its Never Too Late to Stop Smoking,Study Finds
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/27/2017)... Los Angeles, California (PRWEB) , ... May 26, 2017 , ... ... Canadian senior citizens who visit a doctor for colds or respiratory issues that are ... note that excessive time pressure on doctors may be largely responsible for the problem ...
(Date:5/27/2017)... Rosa, CA (PRWEB) , ... May 27, 2017 , ... ... cause for concern, but a new study from the Osteoarthritis Initiative shows ... to developing knee osteoarthritis. Knowing this in advance may give doctors the opportunity to ...
(Date:5/26/2017)... Fairfax, VA (PRWEB) , ... May 26, 2017 ... ... is pleased to announce a new educational seminar to focus on current legislative ... Regulatory News(LEARN) seminar will begin at 1 p.m. Sunday, Sept. 10, and will ...
(Date:5/26/2017)... ... 26, 2017 , ... Boar’s Head Brand®, one of the ... Day entertaining that are sure to satisfy your guests’ flavor cravings, while adding ... cheeses featured in these refreshingly balanced recipes are packed with flavor, creating the ...
(Date:5/26/2017)... ... May 26, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... focusing on the Peace Agreements being discussed by President Donald Trump and the rest ... to try to speed up peace talks in the continuous battle between Israel and ...
Breaking Medicine News(10 mins):
(Date:5/8/2017)... May 8, 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO)., ... ("WRB"), a health care service center company based ... WRB specializes in relationship management programs for leading pharmaceutical ... WRB will join Envoy Health ... services for manufacturers, biotech firms, and other service companies. ...
(Date:5/4/2017)... Tenn. , May 4, 2017  A ... Infection Control, Ultraviolet-C light as a ... Tru-D SmartUVC,s ability to reduce bioburden on anesthesia ... bioburden reduction on high-touch, complex medical equipment surfaces ... surgical infections. "This study further validates ...
(Date:5/4/2017)...   BioLife Solutions , Inc. (NASDAQ: ... proprietary clinical grade hypothermic storage and ... announced that the Company,s first quarter 2017 financial results ... 11, 2017, and that the Company will host a ... that afternoon. Management will provide an overview of the ...
Breaking Medicine Technology: